Research ArticleArticle
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury
Xiuli Li, Kan Zhong, Zitao Guo, Dafang Zhong and Xiaoyan Chen
Drug Metabolism and Disposition November 2015, 43 (11) 1751-1759; DOI: https://doi.org/10.1124/dmd.115.064121